Scarica l'app Stockscreener
29.13
2.08%
-0.62
Dopo l'orario di chiusura:
29.13
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Empowered Funds LLC Sells 104,871 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) to Release Quarterly Earnings on Thursday - MarketBeat
Collegium Pharmaceutical (COLL) Expected to Announce Quarterly Earnings on Thursday - Defense World
Collegium Pharmaceutical (NASDAQ:COLL) versus Atea Pharmaceuticals (NASDAQ:AVIR) Critical Survey - Defense World
When (COLL) Moves Investors should Listen - Stock Traders Daily
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025 - GlobeNewswire
Collegium Pharmaceutical, Inc. to Report Q4 and Full-Year 2024 Financial Results on February 27, 2025 - Nasdaq
Earnings Alert: Collegium Sets Critical Q4 & FY2024 Financial Results DateMark Your Calendar - StockTitan
Collegium Pharmaceutical expands board, appoints new director - MSN
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.60 Average Target Price from Analysts - Defense World
Robeco Institutional Asset Management B.V. Has $293,000 Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical (NASDAQ:COLL) Price Target Lowered to $36.00 at Piper Sandler - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Position Raised by Caprock Group LLC - Defense World
Piper Sandler Has Lowered Expectations for Collegium Pharmaceutical (NASDAQ:COLL) Stock Price - Defense World
Collegium Pharmaceutical, Inc. Appoints Nancy S. Lurker to Its Board of Directors -February 05, 2025 at 08:00 am EST - Marketscreener.com
Collegium Pharmaceutical expands board, appoints new director By Investing.com - Investing.com Australia
Collegium Pharmaceutical expands board with new director - MSN
Collegium Appoints Nancy S. Lurker to its Board of Directors - citybiz
Collegium Pharmaceutical expands board with new director By Investing.com - Investing.com South Africa
Collegium Pharmaceutical Expands Board with Nancy Lurker - TipRanks
Collegium Pharmaceutical Insiders Sell US$2.3m Of Stock, Possibly Signalling Caution - Simply Wall St
SG Americas Securities LLC Sells 4,586 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. announces an Equity Buyback for $100 million worth of its shares. - Marketscreener.com
Pacer Advisors Inc. Trims Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Nisa Investment Advisors LLC Has $71,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Amid more drug-price scrutiny, biopharma companies largely keep their January hikes in check - FiercePharma
Collegium Pharmaceutical Appoints Chief Financial Officer and New Member to its Board of Directors - ACCESS Newswire
Collegium Pharmaceutical, Inc. to Host Earnings Call - ACCESS Newswire
Assenagon Asset Management S.A. Trims Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Assenagon Asset Management S.A. Has $4.31 Million Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Ritholtz Wealth Management Has $968,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Needham Upgrades Collegium Pharmaceutical (COLL) - MSN
Burney Co. Sells 38,157 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $43.80 - Defense World
Collegium pharmaceutical EVP Shirley Kuhlmann sells $908,627 in stock By Investing.com - Investing.com Australia
Insider Selling: Collegium Pharmaceutical, Inc. (NASDAQ:COLL) EVP Sells 27,500 Shares of Stock - MarketBeat
Despite the downward trend in earnings at Collegium Pharmaceutical (NASDAQ:COLL) the stock swells 18%, bringing three-year gains to 82% - Simply Wall St
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
JPMorgan Chase & Co. Has $10.71 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
JPMorgan Chase & Co. Grows Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):